Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Prices $2.2B in Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific has priced three series of senior notes totaling $2.2 billion in aggregate.

The firm is offering $300 million aggregate principal amount of 2.05 percent senior notes due 2014; $900 million aggregate principal amount of 3.2 percent senior notes due 2016; and $1 billion aggregate principal amount of 4.5 percent senior notes due 2021.

It expects to close the offering on Feb. 22, and said that the notes will pay interest on a semi-annual basis.

Thermo Fisher will use the proceeds to pay for its $2.1 billion acquisition of Dionex, which was announced in December.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.